Share This Link

Insulin therapy does not cure diabetes but helps manage blood glucose levels.

Insulin therapy can lead to weight gain in some individuals due to improved glucose utilization, but its primary purpose is to regulate blood glucose.

Insulin therapy aims to decrease blood glucose levels, not increase them.

Type 2 diabetes may initially be managed with oral medications, diet, and exercise, and insulin therapy might be added later if other treatments are not effective.

Gestational diabetes usually involves dietary changes and monitoring blood glucose levels. Insulin therapy may be necessary in some cases, but it is not typically the first-line treatment.

Pre-diabetes indicates higher-than-normal blood glucose levels, but insulin therapy is not usually required at this stage.

Insulin is a protein and would be broken down in the digestive system if taken orally.

Intravenous administration is not commonly used for insulin therapy due to the rapid onset of action and risk of hypoglycemia.

Intramuscular administration is not common for insulin therapy because absorption may be unpredictable and could lead to variability in blood glucose control.

Insulin therapy does not stimulate the pancreas to produce more insulin; it directly provides insulin from an external source.

Insulin therapy does not target insulin resistance in muscle cells but provides the missing insulin.

Insulin therapy does not aim to increase glucose production by the liver; instead, it helps regulate glucose utilization and storage.

Individuals with normal blood glucose levels do not require insulin therapy.

Allergies to insulin are extremely rare, and insulin therapy can still be considered after careful evaluation.

Insulin therapy may be considered for gestational diabetes if blood glucose levels are not well-controlled with diet and exercise, but it is not the first-line treatment.

Short-acting insulin has a slightly slower onset than rapid-acting insulin.

Intermediate-acting insulin has a slower onset and a longer duration of action than rapid-acting insulin.

Long-acting insulin has a slow and steady onset of action over a longer period compared to rapid-acting insulin.

Rapid-acting insulin is used to control post-meal glucose spikes.

Short-acting insulin is used to cover mealtime glucose elevations.

Intermediate-acting insulin provides coverage beyond mealtime but does not mimic basal insulin as closely as long-acting insulin.

Short-acting insulin can also be used in insulin pumps but may not provide as flexible dosing options as rapid-acting insulin.

Intermediate-acting insulin has a longer duration and may not be ideal for the dynamic dosing required in insulin pumps.

Long-acting insulin's slow onset and steady release make it less suitable for insulin pump therapy.

Rapid-acting insulin is clear in appearance.

Short-acting insulin is clear in appearance.

Long-acting insulin is clear in appearance.

Short-acting insulin can also cover meals and snacks, but it may not be as rapid-acting as the name suggests.

Intermediate-acting insulin provides coverage beyond mealtime and is not specifically designed for mealtime glucose control.

Long-acting insulin provides a steady baseline and is not intended for mealtime coverage.

IM injection is not a common route for insulin administration and has a slower onset than subcutaneous injection.

IV infusion provides a rapid onset of action, making it inappropriate for routine insulin administration.

Inhalation is not a typical route for insulin administration. It is used for specific types of medications, not insulin.

Inserting the needle at a 90-degree angle may result in intramuscular injection, leading to rapid absorption and potential hypoglycemia.

Inserting the needle at a 30-degree angle may result in shallow injection and inadequate insulin absorption.

Pressing the needle against the skin and releasing quickly may result in the medication leaking out of the injection site.

The upper arm is not typically recommended for insulin injection due to limited subcutaneous tissue and potential discomfort.

The thigh is also a suitable site for insulin injection, but the abdomen is often preferred in children.

The buttock is not commonly used for insulin injection due to difficulties in self-administration and limited visibility.

Freezing insulin can alter its efficacy and should be avoided.

Insulin stored in the refrigerator should not be warmed before injection, as this can lead to temperature-related degradation.

Storing insulin in a hot environment can lead to degradation and loss of effectiveness.

Drawing up intermediate-acting insulin first can contaminate the vial with rapid-acting insulin, potentially altering dosing accuracy.

The order in which insulin is drawn up does matter to prevent contamination.

Regular insulin is not commonly used for injection in routine insulin therapy.

Basal insulin is not administered before meals; it is intended to regulate fasting glucose levels.

Basal insulin does not cover carbohydrates consumed in meals; it targets basal glucose levels.

Rapid-acting insulin is not synonymous with basal insulin; they serve different purposes in insulin therapy.

Mealtime insulin is usually administered multiple times a day, not as a single daily injection.

Mealtime insulin is not typically a long-acting insulin; it is rapid-acting or short-acting insulin.

Mealtime insulin is administered before or after each meal, not only for the evening meal.

Injecting into the same site each time can lead to lipohypertrophy and uneven insulin absorption.

While the abdomen is a common injection site, rotating within the same area is essential to prevent tissue damage.

Insulin absorption rates are similar across different anatomical sites, so there is no "fastest" absorption site.

Glucagon is administered differently from insulin injections and is intended for emergency use during severe hypoglycemia.

Glucagon is not available in oral tablet form due to its protein nature, which would be broken down in the digestive system.

Glucagon is not typically administered intravenously but rather through subcutaneous or intramuscular injection for rapid action.

Injecting 10 units of insulin for every 1 gram of carbohydrates would result in excessive insulin dosing and potential hypoglycemia.

Consuming 10 units of insulin for every 1 unit of carbohydrates would lead to excessive insulin administration and hypoglycemia.

Injecting 1 unit of insulin for every 10 grams of carbohydrates would result in insufficient insulin dosing and potentially high blood glucose levels.

Increasing the insulin dose without healthcare provider guidance may lead to further hypoglycemia and potential harm.

Consuming more carbohydrates may provide temporary relief from hypoglycemia but does not address the underlying insulin dosing issue.

Skipping meals can lead to unstable blood glucose levels and is not a recommended approach to managing insulin therapy.

Administering rapid-acting insulin after meals targets postprandial glucose levels, not fasting hyperglycemia.

Skipping meals is not a recommended approach and may lead to further blood glucose imbalances.

Decreasing insulin doses may worsen hyperglycemia and is not appropriate without healthcare provider guidance.

Administering the same insulin dose regardless of carbohydrate content can lead to inconsistent blood glucose control.

Monitoring blood glucose levels only once daily does not provide enough information for effective insulin dosing adjustments.

The described approach involves using insulin types inappropriately for their intended purposes.

Decreasing insulin doses without proper monitoring can lead to hypoglycemia during or after physical activity.

Skipping insulin doses can result in elevated blood glucose levels and is not recommended.

Administering extra insulin doses without monitoring blood glucose levels can lead to unpredictable outcomes and potential harm.

Skipping insulin doses can lead to hyperglycemia and unstable blood glucose levels, especially during fasting.

Decreasing the insulin dose without appropriate guidance can result in poor blood glucose control.

Stopping insulin therapy abruptly can lead to hyperglycemia and potential complications. Insulin adjustments should be made under healthcare provider supervision.

Storing insulin in the refrigerator is the correct way to maintain its effectiveness.

Gently rolling the insulin vial before use helps mix the solution but does not pertain to storage.

Checking the expiration date before using insulin is an important step to ensure its safety and effectiveness.

Storing insulin pens in the glove compartment of a car exposes them to temperature fluctuations and extreme heat, which can impact their potency.

While an insulated cooler bag can help protect insulin during travel, insulin pens should not be stored in extreme cold.

Placing insulin pens in the freezer is not recommended as it can alter the medication's properties and affect its effectiveness.

Leaving insulin vials on the car dashboard exposes them to heat and temperature fluctuations, which can impact their potency.

Storing insulin in the overhead compartment of an airplane may subject it to extreme cold or heat, affecting its effectiveness.

Freezing insulin is not recommended, as it can alter the medication's properties and impact its efficacy.

Storing insulin in checked baggage on an airplane can expose it to temperature fluctuations and extreme conditions that may affect its potency.

Storing insulin next to electronic devices may subject it to heat, which can impact its effectiveness.

Storing insulin in the glove compartment of a car during sightseeing can expose it to temperature fluctuations and extreme heat, affecting its potency.

Storing insulin in the freezer is not recommended, as it can alter the medication's properties and impact its efficacy.

Storing insulin in direct sunlight can expose it to extreme temperatures and affect its potency.

Leaving insulin in a parked car, even with cracked windows, exposes it to temperature fluctuations and extreme heat, which can impact its effectiveness.

Carrying a source of fast-acting carbohydrates, like glucose tablets or juice, helps quickly raise blood sugar levels during an episode of hypoglycemia.

Checking blood sugar levels when experiencing symptoms of hypoglycemia helps confirm if blood sugar is low and guides appropriate treatment.

Notifying the healthcare provider about frequent hypoglycemia episodes is important to adjust the diabetes management plan and prevent future occurrences.

Administering a long-acting insulin injection would not address the immediate need to raise blood sugar levels during an episode of hypoglycemia.

Providing a high-fat snack would not rapidly increase blood sugar levels and alleviate symptoms of hypoglycemia.

Giving a rapid-acting insulin injection would further lower blood sugar levels and worsen hypoglycemia symptoms.

Administering glucagon injection is indicated for severe hypoglycemia when the client is unconscious or unable to swallow.

Starting an IV glucose infusion is reserved for severe hypoglycemia cases that are unresponsive to other interventions or when the client is unable to tolerate oral intake.

Monitoring blood sugar levels every 4 hours is a routine practice but does not address the immediate need to treat hypoglycemia.

Administering an oral glucose solution is not appropriate for an unconscious client who cannot swallow.

Initiating an insulin infusion would further lower blood sugar levels and worsen the hypoglycemic state.

Encouraging the client to consume a high-protein meal is not feasible for an unconscious client.

Applying the gel topically to the skin will not effectively raise blood sugar levels and alleviate hypoglycemic symptoms.

Massaging the gel into the site of injection is not appropriate, as glucose gel is meant to be swallowed.

Rubbing the gel between the palms and inhaling deeply will not have a significant impact on blood sugar levels.

Rotating injection sites between different anatomical areas helps prevent lipohypertrophy and ensures consistent absorption.

Insulin vials can be kept at room temperature for up to 28 days once in use, but they should be stored away from direct sunlight and extreme temperatures.

Eating a meal or snack within 15 minutes of taking rapid-acting insulin helps prevent hypoglycemia and ensures that the insulin is working when glucose levels rise after eating.

Cleaning the injection site with an alcohol swab before injection is a recommended practice to prevent infection.

Insulin pens are a convenient and accurate way to measure and administer insulin doses.

Rotating injection sites helps prevent lipohypertrophy and ensures consistent absorption.

Storing insulin vials in the refrigerator helps maintain their potency, but they can be kept at room temperature for up to 28 days once in use.

Checking the expiration date on insulin vials is important to ensure their effectiveness and safety.

Gently rolling the insulin vial between palms helps mix the insulin if it appears cloudy, but it should not be done with clear insulin.

Keeping glucose tablets or gel on hand is a recommended practice to rapidly raise blood sugar in case of hypoglycemia.

Eating a high-protein snack can help stabilize blood sugar and prevent it from dropping too low.

Following up with a healthcare provider about frequent episodes of hypoglycemia is important to adjust insulin therapy and prevent future episodes.

Cleaning hands with soap and water before using the glucose meter is a good practice to ensure accurate readings.

Applying a lancet to the side of the fingertip is a correct technique to obtain a blood sample for glucose testing.

Testing blood sugar regularly, regardless of symptoms, helps monitor and manage glucose levels effectively.

This statement is incorrect. While insulin therapy is commonly associated with type 1 diabetes, it can also be used in type 2 diabetes when other treatments are not sufficient.

Insulin therapy does not cure diabetes. It helps manage blood sugar levels and prevents complications, but it does not eliminate the underlying condition.

Insulin therapy may be used temporarily, but it can also be a long-term treatment option for type 2 diabetes, especially if other treatments are not effective.

Adjusting insulin dose based on how one feels is not a safe or accurate method. Insulin dosing should be guided by healthcare provider recommendations.

Starting with a high dose of insulin is not advisable and can lead to hypoglycemia. Insulin dosing should be started conservatively and adjusted as needed.

While monitoring blood sugar levels before and after meals is important for diabetes management, it is not the sole method for determining insulin dosing. Healthcare provider guidance is essential.

Adjusting insulin dose based on how one feels is not a safe or accurate method. Insulin dosing should be guided by healthcare provider recommendations.

Starting with a high dose of insulin is not advisable and can lead to hypoglycemia. Insulin dosing should be started conservatively and adjusted as needed.

While monitoring blood sugar levels before and after meals is important for diabetes management, it is not the sole method for determining insulin dosing. Healthcare provider guidance is essential.

Taking a long-acting insulin in the morning and evening is consistent with a basal-bolus regimen. This statement is correct.

Using rapid-acting insulin before each meal is consistent with a basal-bolus regimen. This statement is correct.

Rotating injection sites within the same area is a recommended practice to prevent skin changes and complications associated with repeated injections. This statement is correct.

Using a 90-degree angle when inserting the needle is a common technique for insulin injections. This statement is correct.

Avoiding scar tissue and areas with visible blood vessels is important to ensure proper insulin absorption. This statement is correct.

Pinching the skin before inserting the needle can help ensure subcutaneous injection and prevent injecting into muscle. This statement is correct.

Basal insulin indeed provides a steady amount of insulin to cover the body's basic metabolic needs between meals and overnight. This statement is correct.

Prandial insulin does help control the rise in blood sugar after meals. This statement is correct.

Prandial insulin is indeed a type of rapid-acting insulin used to cover meals and control post-meal blood sugar levels. This statement is correct.

Drawing up short-acting insulin before long-acting insulin is a recommended practice to prevent contamination of the long-acting insulin vial.

Rotating injection sites within the same anatomical area helps prevent lipohypertrophy and ensures consistent absorption.

Insulin vials should be kept refrigerated to maintain their potency, but they can be kept at room temperature for up to 28 days once in use to prevent discomfort from cold injections.

Administering short-acting insulin in the morning and long-acting insulin at bedtime does not coincide with the timing needed to control glucose levels effectively.

Short-acting and long-acting insulins should not be mixed in the same syringe to maintain their proper dosing and actions.

Administering long-acting insulin right after a meal would not match the onset and duration of action needed for glucose control.

Insulin glargine (Lantus) is a U-100 insulin and should be administered using a U-100 insulin syringe.

Lantus can be injected into the abdomen, thigh, or upper arm to ensure consistent absorption and to prevent lipohypertrophy.

Injecting Lantus at the same time each day helps maintain consistent blood sugar levels and optimize its effectiveness.

Rotating injection sites within the same area helps prevent lipohypertrophy and ensures consistent absorption.

Administering regular insulin before meals aligns with the timing needed to cover postprandial glucose spikes.

Using a 45-degree angle for subcutaneous injections is a recommended technique for insulin administration to ensure proper subcutaneous delivery.

Administering insulin lispro within 15 minutes of a meal matches its rapid onset of action, which helps control postprandial glucose levels.

Using an insulin syringe to draw up insulin lispro is an appropriate technique for accurate dosing.

Injecting insulin lispro into the subcutaneous tissue is the correct route of administration for this rapid-acting insulin.